Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

ClinicalTrials.gov ID: NCT00083174

Public ClinicalTrials.gov record NCT00083174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 2:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: The MAP.3 study was designed to test whether hormone therapy using exemestane may prevent breast cancer by blocking the production of estrogen. PURPOSE: The study protocol was amended in May 2011 and the current purpose of the study is to allow all study participants the opportunity to complete 5 years of exemestane.

Study identification

NCT ID
NCT00083174
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NCIC Clinical Trials Group
Network
Enrollment
4,560 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2004 (Actual)
Primary completion
Mar 25, 2011 (Actual)
Completion
Jan 22, 2018 (Actual)
Last update posted
Aug 25, 2023

2004 – 2018

United States locations

U.S. sites
41
U.S. states
26
U.S. cities
37
Facility City State ZIP Site status
Jefferson Clinic, P.C. Birmingham Alabama 35233 —
UAB Comprehensive Cancer Center-LNB 301 Birmingham Alabama 35294-0111 —
Providence Alaska Medical Center Anchorage Alaska 99508 —
University of California, San Diego La Jolla California 92037 —
University of California at Davis Sacramento California 95817 —
Los Angeles Biomedical Research Institute Torrance California 90502 —
University of Connecticut Health Center Farmington Connecticut 06032 —
Whittingham Cancer Center at Norwalk Hospital Norwalk Connecticut 06856 —
The George Washington University Washington D.C. District of Columbia 20037 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
University of Miami School of Medicine Miami Florida 33136 —
Georgia Cancer Specialists Tucker Georgia 30084 —
John H. Stroger, Jr Hospital of Cook County Chicago Illinois 60612 —
Mercy Hospital and Medical Center Chicago Illinois 60616 —
The University of Chicago Medical Center Chicago Illinois 60637-1470 —
Loyola University Medical Centre Maywood Illinois 60153 —
Trinity Medical Center Moline Illinois 61265 —
Mid-Illinois Hematology and Oncology Associates, Ltd. Normal Illinois 61761 —
Carle Cancer Centre Urbana Illinois 61801 —
Indiana University Medical Center Indianapolis Indiana 46202 —
University of Kansas Medical Center Kansas City Kansas 66160-7820 —
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074-9308 —
Suburban Hospital Cancer Program Bethesda Maryland 20817 —
MedStar Health Research Institute Hyattsville Maryland 20782 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Hutzel Women's Health Specialists Detroit Michigan 48201 —
William Beaumont Hospital Royal Oak Michigan 48073 —
Mayo Clinic Rochester Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
University of Medicine and Dentistry of New Jersey Newark New Jersey 07107 —
Montefiore Medical Center The Bronx New York 10461 —
Kinston Medical Specialists Kinston North Carolina 28501 —
University of Cincinnati, Barrett Cancer Centre Cincinnati Ohio 45219 —
University of Oklahoma Oklahoma City Oklahoma 73104 —
Abramson Cancer Center of the Philadelphia Pennsylvania 19104-4283 —
The Memorial Hospital of Rhode Island Pawtucket Rhode Island 02860 —
Fletcher Allen Health Care Burlington Vermont 05401 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024 —
Univ. of Wisconsin Center for Women's Health and Madison Wisconsin 53715 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00083174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2023 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00083174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →